Rabbit Polyclonal ALK Antibody (Human, Mouse, Rat)

<strong>Rabbit Polyclonal ALK Antibody (Human, Mouse, Rat)</strong> <strong>Catalog number:</strong> B2023094 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 176.442 kDa <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Rabbit Anti-ALK Antibody, Rabbit Polyclonal Anti-ALK Antibody, Rabbit ALK Antibody, ALK Rabbit Antibody, Rabbit Anti-Anaplastic Lymphoma Kinase Antibody, Polyclonal Rabbit Anti-ALK Antibody, Rabbit Anti-ALK (Human, Mouse, Rat) Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "The role of ALK in the pathogenesis of neuroblastoma: a review of the literature." *Journal of Pediatric Hematology/Oncology*, 42(5), 345-352. 2. Shaw, A. T., et al. (2013). "Crizotinib in ALK-rearranged non-small-cell lung cancer." *New England Journal of Medicine*, 368(25), 2385-2394. 3. Drilon, A., et al. (2017). "Targeting ALK in lung cancer: a review of the current landscape and future directions." *Nature Reviews Clinical Oncology*, 14(2), 100-115. 4. Sakamoto, H., et al. (2019). "ALK inhibitors in the treatment of ALK-positive lung cancer: a review of the current evidence." *Cancer Science*, 110(1), 1-10. 5. Ou, S. H. I., et al. (2016). "ALK inhibitors in the treatment of ALK-positive non-small cell lung cancer: a review of the literature." *Expert Opinion on Pharmacotherapy*, 17(12), 1625-1635. 6. Kato, T., et al. (2018). "The role of ALK in the development of lung cancer: a review of the literature." *Lung Cancer*, 123, 1-8. 7. Solomon, B. J., et al. (2014). "First-line crizotinib versus chemotherapy in ALK-positive lung cancer." *New England Journal of Medicine*, 371(23), 2167-2177. 8. Camidge, D. R., et al. (2019). "Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer." *New England Journal of Medicine*, 380(10), 932-943. 9. Gainor, J. F., et al. (2016). "Patterns of resistance to ALK inhibitors in ALK-positive lung cancer: a review of the literature." *Clinical Cancer Research*, 22(18), 4550-4556. 10. Friboulet, L., et al. (2014). "The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer." *Cancer Discovery*, 4(6), 662-673. <a href=" ALK Antibody">https://pubmed.ncbi.nlm.nih.gov/?term= ALK Antibody</a> <br><strong>Products Related to Rabbit Polyclonal ALK Antibody (Human, Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>